# Johnson & Johnson to acquire Auris Health for $3.4 billion

Johnson & Johnson, through its subsidiary Ethicon, Inc., has entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies for lung cancer, for approximately $3.4 billion in cash, with additional contingent payments of up to $2.35 billion.

- Type: Acquisition
- Announced: 2021-07-08
- Where: United States
- Value: $3.40B
- Status: announced
- Products: surgical robotics, bronchoscopic diagnostic and therapeutic platforms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [Johnson & Johnson](https://endata.com/companies/9845.md) (acquirer)
- [Ethicon](https://endata.com/companies/22274.md) (acquirer)
- [Auris Health](https://endata.com/companies/37277.md) (target)

## Sources

- [accuprec.com](https://accuprec.com/johnson-johnson-to-acquire-surgical-robotics-firm-auris-health-inc-for-us3-4-billion/), 2021-07-08: "Johnson & Johnson has announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.